Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
PHASE1
The purpose of this study is to see if Panobinostat is safe to give to pati...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator
PHASE2
The study allowed continued use of single agent panobinostat in patients wh...
Status
Completed
Location
City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(1)